ST. LOUIS--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, and PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc. and a leader in radiopharmaceutical distribution, jointly announced they have entered into a co-marketing agreement to offer a combined portfolio of high energy and low energy radioisotopes to the nuclear medicine community in the United States.
